Differences in Characteristics and Treatment Received among Depressed Adolescent Psychiatric Outpatients with and without Co-Occuring Alcohol Misuse: A 1-Year Follow-Up Study by Pirkola, Tiia et al.
Hindawi Publishing Corporation
Depression Research and Treatment
Volume 2011, Article ID 140868, 9 pages
doi:10.1155/2011/140868
Research Article
Differencesin Characteristics and Treatment Receivedamong
DepressedAdolescentPsychiatric Outpatientswithand without
Co-OccuringAlcohol Misuse: A 1-Year Follow-Up Study
TiiaPirkola,1 MirjamiPelkonen,1 Linnea Karlsson,1,2 OlliKiviruusu,1 Thea Strandholm,1
VirpiTuisku,1 TittaRuuttu,1 andMauri Marttunen1,3,4
1Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, P.O. Box 30,
00271 Helsinki, Finland
2Department of Child Psychiatry, The Turku University Central Hospital, P.O. Box 52 Kiinamyllynkatu 4-8, Rak 10,
20521 Turku, Finland
3Department of Adolescent Psychiatry, Helsinki University Central Hospital, P.O. Box 590, 00029 HUS, Helsinki, Finland
4Department of Psychiatry, University of Helsinki, P.O. Box 590, 00029 HUS, Helsinki, Finland
Correspondence should be addressed to Tiia Pirkola, tiia.pirkola@kolumbus.ﬁ
Received 30 June 2010; Revised 30 November 2010; Accepted 14 March 2011
Academic Editor: Robert Milin
Copyright © 2011 Tiia Pirkola et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objectives. We aimed at examining the diﬀerences between depressed psychiatric adolescent outpatients with and without
cooccurring alcohol misuse in psychosocial background, clinical characteristics, and treatment received during one-year followup.
Furthermore, we investigated factors related to nonattendance at treatment. Materials and Methods. Consecutive 156 adolescent
(13–19 years) psychiatric outpatients with a unipolar depressive disorder at baseline were interviewed using structured measures
at baseline and at 12 months. Alcohol misuse was deﬁned as having an AUDIT score of 8 or more points. The outpatients received
“treatment as usual” of clinically deﬁned duration. Results. Among depressive outpatients, poor parental support, parental alcohol
useanddecreasedattendanceattreatmentassociatedwithalcoholmisuse.TheseverityofalcoholuseasmeasuredbyAUDIT-score
wasthestrongestfactorindependentlypredictingnonattendanceattreatmentinmultivariateanalysis.Conclusions.Alcoholmisuse
indicates family problems, has a deleterious eﬀect on treatment attendance, and should be taken into account when managing
treatment for depressive adolescent outpatients.
1.Introduction
Depressive disorders are common among adolescents with
an estimated point prevalence of about 3% to 8%, and with
a lifetime prevalence of approximately 20% by the end of
adolescence [1–3]. Among adolescents, excessive substance
use often co-occurs with depressive illness [4], alcohol being
the most common substance used among Finnish adolescent
population [5, 6]. Studies have found positive associations
of alcohol use frequency and recurrent intoxication among
depressedadolescentsandofearly-onsetdepressivedisorders
with elevated levels of later addictive substance use [5]. It
has been reported that 10–25% of depressed subjects have
cooccurring substance use disorder (SUD) both in general
and clinical populations with clearly higher ﬁgures in clinical
populations [7, 8].
There is evidence that comorbid conditions increase
utilization of psychiatric services, complicate treatment, and
have a negative impact on the course and prognosis of
both disorders [9–13]. Depression and SUD each, and their
cooccurrence in particular, are associated with psychosocial
impairment, more severe symptoms, and increased suicidal-
ity [4, 14–19]. The growing literature emphasizes the clinical
importance of substance use not reaching the diagnostic
threshold in young people [10, 20] as it seems to associate
with a greater number of other psychiatric symptoms [20].
Despite recognized risks of adolescent substance use
among depressed juvenile patients, studies focusing on2 Depression Research and Treatment
treatment of cooccurring depression and SUD are still scarce
[21]. The outcome of treating either disorder alone is known
to be unsatisfactory [22, 23]. Cornelius et al. [24]s u g g e s t e d
that psychological intervention should be considered ﬁrst-
line treatment for this population, with pharmacotherapy
oﬀered to those who do not respond to this intervention
alone. In the study by Riggs et al. [25], the combination of
ﬂuoxetine and cognitive behavioural therapy (CBT) showed
superior eﬃcacy to that of placebo and CBT for MDD
according to changes of the Childhood Depression Rating
Scale-Revised in adolescents with SUD. The relative gap
of our knowledge is partly due to historical separation of
and lack of coordination between substance and mental
health treatment programs in many countries. Furthermore,
in controlled treatment studies, patients with comorbid
disorders are usually excluded [21, 26]. In psychiatric clinical
practise, it seems that substance-related problems are not
detected at all or diagnosed too late leading to a lack or
delay of treatment, as Couwenbergh et al. have pointed
out [27]. For the development of speciﬁc treatments for
these adolescents with comorbid disorders, more research is
needed.
The present study seeks to add to the limited research on
treatmentofdepressioninthecontextofcooccurringalcohol
use and on factors related to nonattendance at treatment
in depressed adolescents. We analyzed data from a Finnish
naturalisticone-yearfollow-upstudyofdepressedadolescent
outpatients. Our aim was to examine the diﬀerences in psy-
chosocial background characteristics and treatment received
during the one-year follow-up time of depressed psychiatric
outpatientadolescentswithandwithoutcooccurringalcohol
misuse and to investigate factors related to nonattendance at
treatment in this population.
2.MaterialsandMethods
2.1. Subjects and Measures. This study forms part of the
Adolescent Depression Study (ADS), a collaboration study
between the Department of Adolescent Psychiatry of Peijas
Medical Health Care District (PMCD) of Helsinki University
Central Hospital and the Department of Mental Health
and Substance Abuse Services of the National Institute
for Health and Welfare (former National Public Health
Institute), Finland. The study protocol was accepted by the
ethics committees of Helsinki University Central Hospital
and PMCD.
The ADS is a naturalistic clinical research and develop-
ment project on adolescent depressive mood disorders in
a sample of consecutive adolescent psychiatric outpatients.
The study population was drawn from the PMCD’s two
adolescent psychiatric outpatient clinics between February 1,
1998 and December 31, 2001. PMCD covers approximately
210,000 inhabitants (about 15% adolescents) of the Helsinki
metropolitan area in southern Finland. The outpatient
clinics in the PMCD oﬀer secondary care to all 13- to 19-
year-old citizens. Patients are mainly referred from schools,
healthcarecenters,andsocialandfamilycounselingservices.
Subjectsbelievedtohaveapredominantandseveresubstance
use disorder (SUD) and the most severe eating disorders are
oﬀered treatment elsewhere in specialized units. Finland has
universal access to health care, and adolescent psychiatric
care is free of charge for the patient. The outpatient clinics
oﬀer eclectic psychiatric treatment including individual
supportive therapy, family consultations, and psychotropic
medication when appropriate.
The screening and diagnostic procedure and the study
population (n = 218) of the ADS study have been described
in more detail previously [3, 28]. In brief, of the 774 consec-
utive outpatients, 660 (85.3%) were considered eligible. The
exclusion criteria were age below 13 or over 19 years, mental
retardation, insuﬃcient knowledge of the Finnish language,
or admission including no individual appointments. The
patient sampling for ADS involved screening all patients
by the Beck Depression Inventory-21 [29] and the General
Health Questionnaire-36 self-report measures [30]. Studies
have supported the reliability and validity of BDI-21 and
GHQ-36 also among adolescent populations [31–34]. The
sum scores ≥10 on the BDI-21 and ≥5 on the GHQ-36 were
considered screening positives and were invited to partici-
pate. Screening positives were fully informed of the study
project, and written informed consent was requested from
bothparticipantsandtheirparentsfromthoseunder18years
of age. Of the eligible patients, 373 (56.5%) were screen pos-
itives. Of the screen positives, 221 (59.2%) agreed to partici-
pateinthestudyandweretheninterviewed.Almostallofthe
interviewed subjects (N = 218) had an ongoing episode of
either unipolar or bipolar depression at baseline evaluation
and were recruited to the study. Adolescent who declined to
participate were similar to the study subjects in terms of age,
sex, and parental socioeconomic status while they tended to
have lower BDI-21 (19.0 versus 21.0, z =− 1.93, df = 371,
P = .05) and lower GHQ-36 (21.0 versus 24.0, z =− 1.98,
df = 367, P = .05) median sum scores [3, 8].
Data were obtained by interviewing the adolescents
themselves and collecting additional background data from
the clinical records. In clinical practice, at baseline, parents
were oﬀered at least one consultation appointment and
data on adolescent’s as well as parental problems were
collected. Special eﬀorts were made in order to conﬁrm
that all data in clinical records were appropriate, right, and
timed. In a naturalistic manner, after the comprehensive
baseline evaluation (T1), the outpatients received “treatment
as usual” of clinically deﬁned duration. The study subjects
were reevaluated in 6 months and one year (T2). The
median time interval between T1 and T2 was 59.5 weeks
(interquartile range (IQR), 57.0–63.0 weeks).
Excluded for the analyses of this study were those
subjects (1) who were diagnosed either at the baseline or
at later diagnostic interviews as having bipolar disorder
(n = 21), (2) with missing data of Alcohol Use Disorder
Identiﬁcation Test (AUDIT) [35] at baseline (n = 12),
and (3) who did not participate in the one-year interview
(n = 29). Consequently, the ﬁnal study population of this
study comprised of 156 patients with diagnosed unipolar
depression. For the analyses, the subjects were classiﬁed into
two groups according to level of self-reported alcohol use
at baseline: (1) nonmisusers (n = 86) had AUDIT score
of less than 8 and (2) alcohol misusers (n = 70) hadDepression Research and Treatment 3
A U D I Ts c o r eo f8o rm o r e .T h ec u t o ﬀ point of 8 in AUDIT
was chosen based on previous research [35, 36]. AUDIT
is a self-report measure to assess alcohol-related problems,
which is a commonly used and a clinically meaningful
instrument in ordinary clinical practice. The AUDIT has
reasonable psychometric properties among adolescents [35,
37–39].
2.2. Sociodemographic, Diagnostic, and Clinical Characteris-
tics at Baseline. Sex and age at baseline were taken directly
from the data. The socioeconomic status (SES) of the ado-
lescent’s parents was classiﬁed as follows: upper middle class,
lower middle class, working class, or other (including stu-
dents, unemployed, retired (pensioner), others not deﬁned)
[40].Parents’divorce,alcoholuse,ormentalhealthproblems
were recorded based on the information received from the
subjects and/or the parents. Social support was assessed by
the Perceived Social Support Scale-Revised (PSSS-R) [41].
PSSS-R measures persons’ subjective perceptions of social
support and emotional closeness, not actual number of
supportive contacts. It has been shown to be a useful method
in assessing perceived social support in Finnish adolescents
[42, 43].
T h eS c h e d u l ef o rA ﬀective Disorders and Schizophrenia
for School-Aged Children—Present and Life-time version
(K-SADS-PL) [44] was used to assess present and lifetime
episodes of DSM-IV Axis I disorders. The DSM-IV Axis II
disorderswereassessedwiththeStructuralClinicalInterview
for DSM-IV Axis II Disorders (SCID-II) interview [45]. For
the analyses, Axis II diagnoses were dichotomized (yes/no
Axis II diagnose). Axis III diagnoses were dichotomized
according to whether the patient had any doctor-diagnosed
medical condition or not. Nine researchers, who were expert
level clinicians (educated psychiatrists and psychologists),
conducted the diagnostic interviews, and all the research
diagnoses were conﬁrmed in a subsequent diagnostic meet-
ing.Interraterreliability,assessedusing15randomlyselected
videotaped interviews, was good for mood disorder diag-
noses (weighted kappa [46, 47] for MDD, other mood
disorder, no mood disorder 0.87 (95% CI 0.81, 0.93))
[3].
Current psychosocial functioning (Global Assessment of
Functioning, GAF) was assessed according to the DSM-
IV Axis V deﬁnitions [48], that is, indicating the level of
functioning at the time of the interview. For the group
comparisons, the GAF score was used as a dichotomous
variable, with a cut-point of 60 indicating “at least moderate
impairment” [3, 8].
Severity of depression was measured by Beck Depression
Inventory (BDI-21) [29] total sum-scores (range 0 to 60).
Alcohol misuse was assessed by the AUDIT sum-score (range
0 to 40), severity of anxiety symptoms was measured by
using the sum-score (range 0 to 63) of the Beck Anxiety
Inventory (BAI) [49] and severity of suicidality by using
the sum-score of the Scale for Suicidal Ideation (SSI)
[50].
Age of onset of depression was recorded based on the
information collected from the clinical records and at the
interview.
2.3. Treatment. As the study was naturalistic, the outpatients
received“treatmentasusual”ofclinicallydeﬁneddurationin
a general adolescent psychiatric setting of Finnish secondary
health care. The treatment team consists of a psychiatrist
specialized in adolescent psychiatry, a psychologist, one or
more psychiatric nurses, and a social worker. The treat-
ment modalities used at the outpatient clinics consisted
of individual supportive therapy, family consultations, and
psychotropic medication when appropriate. The treatment
always begun with an evaluation phase. The information of
treatmentreceivedwasgatheredfromtheone-yearfollow-up
data. At the one-year follow-up time, 65,4% of the subjects
were continuing their treatment.
2.3.1. Psychosocial Treatment. Following data were gathered
from the medical records: number of scheduled and kept
individual appointments, number of scheduled and kept
family/network appointments, intensity (kept individual
appointments/month),andattendanceattreatment (propor-
tion of kept to scheduled individual appointments).
2.3.2. Pharmacological Treatment. The information of phar-
macological treatment was used as a dichotomous variable
(yes/no prescribed medication during the treatment/one-
year follow-up time) in the following medication groups: (1)
Serotonin reuptake inhibitors (SSRI:s), (2) other antidepres-
sant medication, (3) anxiolytics, (4) antipsychotics, and (5)
other psychotropic medication.
Combinedtreatment wasclassiﬁedasfollows:(1)individ-
ual psychotherapy, (2) individual psychotherapy and family
counseling, (3) individual psychotherapy and medication,
and (4) individual psychotherapy, family counseling, and
medication. The information of hospitalization was used
as a dichotomous variable (yes/no hospitalization during
the one-year follow-up time). In addition, the number of
hospitalization days during the treatment was recorded.
2.4. Diagnostic and Clinical Characteristics at One-Year
Followup. At one-year followup, the severity of depression
was measured by the BDI-21. Total sum score and the
level of psychosocial functioning (Global Assessment of
Functioning, GAF) were assessed according to the DSM-
IV Axis V deﬁnitions. Level of alcohol use was assessed by
using the AUDIT sum-score. The diagnostic status of the
depressive disorder at the time of the one-year follow-up
diagnostic interviews was rated as follows: (1) recovery, (2)
persistent depression, and (3) recurrence during the study
period. Two months of 1 or no symptoms (no depressed or
irritable mood or anhedonia) was deﬁned as recovery. Lack
ofrecoveryduringtheone-yearfollow-upperiodwasdeﬁned
as persistent depression. Recurrence was deﬁned as a new
depressive episode emerging after the beginning of recovery.
2.5. Statistical Analysis. To analyze diﬀerences between alco-
hol misusers and nonmisusers, we used Chi-square for the
categorical variables, t-test for normally, and Mann-Whitney
U tests for non-normally distributed continuous variables.
To analyze factors independently associating with treatment4 Depression Research and Treatment
Table 1: Sociodemographic, diagnostic, and clinical characteristics of depressed outpatients by alcohol use at baseline (n = 156).
Characteristic Nonmisusers (Audit <8) (86) Alcohol misusers (Audit ≥8) (70) P value
Sex, no. (%) .51
Male 17 (19.8) 11 (15.7)
Female 69 (80.2) 59 (84.3)
Age at baseline, mean (SD; median) 16.3 (1.5; 17.0) 16.5 (1.7; 17.0) .64
SES of parents, no. (%) .19
Upper middle cl 23 (26.7) 18 (25.7)
Lower middle cl 38 (44.2) 21 (30.0)
Working class 19 (22.1) 25 (35.7)
Other 6 (7.0) 6 (8.6)
Divorce of parents, no. (%) 36 (41.9) 31 (44.3) .65
Parents’ mental health problems, no. (%) 35 (42.2) 28 (43.1) .91
Parents’ alcohol use problems, no. (%) 31 (36.9) 35 (53.0) .048
Perceived social support
Total, mean (SD; median) 44.7 (11.2; 46.5) 43.5 (8.9;44.5) .17
Close/intimate friend 16.1 (4.9; 18.0) 16.7 (4.1;18.0) .63
Family 13.8 (4.4; 14.0) 11.6 (4.7;11.5) .004
Friends 14.9 (5.1; 16.5) 15.2 (4.8;16.0) .87
Age of 1st mood disorder, mean (SD; median) 13.4 (2.5; 13.5) 13.2 (2.9; 13.0) .67
Depression diagnosis, no. (%) .75
MDD single 45 (52.3) 36 (51.4)
MDD recurrent 21 (24.4) 20 (28.6)
Dysthymia/Douple dep 13 (15.1) 7 (10.0)
Minor 7 (8.1) 7 (10.0)
Axis I: any comorbidity, no. (%) 62 (72.1) 52 (74.3) .76
Any SUD, no. (%) 4 (4.7) 22 (31.4) <. 001
Axis II: any comorbidity, no. (%) 30 (34.9) 28 (41.2) .42
Axis III: medical comorbidity, no (%) 29 (33.7) 14 (20.0) .56
Axis V: GAF score <60, no. (%) 64 (74.4) 61 (87.1) .048
BDI score at baseline, mean (SD; median) 21.0 (8.7; 19.5) 23.8 (8.8; 24.5) .03
AUDIT score at baseline, mean (SD; median) 2.7 (2.4; 2.0) 14.4 (5.9; 12.0) <.001
BAI score at baseline, mean (SD; median) 20.8 (11.4; 19.0) 22.9 (12.2; 20.0) .38
SSI score at baseline, mean (SD; median) 4.1 (7.1; 0) 5.8 (7.2; 3.0) .12
attendance, a logistic regression model was conducted with
response variable (=attendance) equal to the binomial
proportion of kept to scheduled individual appointments.
Possibly compliance-related clinical and treatment factors
were the explanatory variables including AUDIT and BDI
scores at baseline, perceived social support from the family,
psychosocial functioning (GAF score), comorbid axis I
and axis II diagnoses at baseline, and prescribed use of
psychotropic medication. In this model, the AUDIT, BDI,
GAF,andPSSS-Rscoresweretreatedascontinuousvariables.
T h em o d e lw a sa d j u s t e df o ra g ea n ds e x .P values <. 05 were
considered statistically signiﬁcant. Statistical analyses were
carried out using SPSS14.0 softwarepackage[51]a n dP A S W
18.0 [52].
3. Results
3.1. Characteristics at Baseline. The adolescents with and
without alcohol misuse did not diﬀer signiﬁcantly in terms
of gender, age, or parental socioeconomic status. Those with
a l c o h o lm i s u s eh a dp e r c e i v e dl e s ss o c i a ls u p p o r tf r o mt h e i r
families (11.6 versus 13.8, P<. 01), had worse psychosocial
functioning as measured by GAF score (GAF score < 60,
87.1% versus 74.4%, P<. 05), higher mean BDI scores
(23.8 versus 21, P = .03), and their parents had more often
problems with alcohol use (53.0% versus 36.9%, P<. 05),
(Table 1). The mean of the AUDIT score for the alcohol
misusers was 14.4 compared to 2.7 of nonmisusers. Alto-
gether, six subjects had other than alcohol related-substanceDepression Research and Treatment 5
Table 2: Treatment received of depressed outpatients by alcohol use during the one-year follow-up period (n = 156).
Characteristic Nonmisusers (Audit < 8) (86) Alcohol misusers (Audit ≥ 8) (70) P value
Psychosocial treatment
(i) Kept individual appointments, no. (%) .35
<10 15 (17.4) 17 (24.3)
10–25 42 (48.8) 36 (51.4)
>25 29 (33.7) 17 (24.3)
(ii) Kept family/network appoint, mean (SD; median) 1.4 (1.9; 1.0) 1.2 (2.1;0.0) .34
(iii) Intensity (individual appoint/month), mean (SD; median) 1.9 (1.1; 1.8) 1.5 (0.8; 1.3) .04
(iv) Attendance % (individual appoint), mean (SD; median) 76.5 (15.6; 76.0) 68.8 (15.8; 68.5) .004
Psychotropic medications
Any, no (%) 42 (48.8) 48 (68.6) .01
(i) Antidepressants 39 (45.3) 41 (58.6) .10
SSRI 38 (44.2) 39 (55.7) .15
other antidepressants 8 (9.3) 13 (18.6) .17
(ii) anxiolytics/ sedatives 20 (23.3) 26 (37.1) .06
(iii) antipsychotics 8 (9.3) 11 (15.7) .22
(iv) other 4 (4.7) 3 (4.3) .66
Combined treatment, no. (%) .21
Individual psychotherapy 20 (23.3) 17 (24.3)
+ family counselling 27 (31.4) 12 (17.1)
+ medication 19 (22.1) 21 (30.0)
+ medic + family 20 (23.3) 20 (28.6)
Hospitalization, no. (%) 13 (15.1) 10 (14.3) .88
Number of hospitalization days, mean (SD; median) 13.3 (48.5; 0.0) 10.4 (32.9; 0.0) .89
Treatment status at the one-year followup, no. (%) .47
(i) No treatment 30 (34.9) 24 (34.3)
(ii) Psychiatric outpatient 55 (64.0) 43 (61.4)
(iii) Psychiatric inpatient 1 (1.2) 3 (4.3)
Table 3: Diagnostic and clinical characteristics of depressed outpatients at the one-year followup (by the alcohol use at baseline) n = 156.
Characteristic Nonmisusers (Audit < 8) (86) Alcohol misusers (Audit ≥ 8) (70) P value
BDI score, mean (SD; median) 7.2 (7.8; 6.0) 9.7 (9.5; 7.0) .045
Axis V: GAF score < 60, no. (%) 32 (37.2) 38 (55.1) .03
AUDIT score, mean (SD; median) 4.2 (4.5; 3.0) 10.8 (6.4; 10.0) <. 001
Diagnostic status, no. (%) .73
recovery 32 (37.2) 26 (37.1)
persistent depression 42 (48.8) 37 (52.9)
recurrence 12 (14.0) 7 (10.0)
Any SUD, no. (%) 1 (1.2) 13 (18.6) <. 001
use at diagnosed level, two in the alcohol nonmisusers
group (both amphetamine-related disorder NOS), and four
in the alcohol misusers group (three cannabis abuse, and one
amphetamine-related disorder NOS).
3.2. Treatment Characteristics during the Follow-Up Period.
By the one-year follow-up time point, those with alcohol
misusehadlowertreatmentintensityscores(mean1.5versus
1.9, P = .04) and a poorer attendance measure (68.8%
versus 76.5%, P<. 01) than the nonmisusers. They had also
more often received psychotropic medication (68.6% versus
48.8%, P = .01; Table 2).
3.3. Diagnostic and Clinical Characteristics at One-YearFoll-
owup. Those with alcohol misuse had higher BDI score
(mean 9.7 versus 7.2, P<. 05) and higher AUDIT score6 Depression Research and Treatment
Table 4: Logistic regression analysis of treatment attendance1 during one-year followup on baseline clinical and treatment-related
characteristics.
Wald χ2 PO R [95% CI]
Age at baseline 0.960 .327 1.03 [0.98–1.08]
Sex 0.626 .429 0.92 [0.74–1.14]
BDI score 0.245 .621 1.00 [1.00–1.01]
AUDIT score 56.009 <. 001 0.97 [0.96–0.97]
Axis I: any comorbidity 2.251 .134 1.14 [0.96–1.36]
Axis II: any comorbidity 17.143 <. 001 1.44 [1.21–1.71]
Axis V: GAF score 2.259 .133 0.13 [1.0–1.02]
Perceived social support from the family 0.142 .706 1.00 [0.99–1.02]
Psychotropic medication, any 0.017 .895 0.99 [0.83–1.18]
1Proportion of kept to scheduled individual appointments.
(mean 10.8 versus 4.2, P<. 001), and 55.1% of them had
GAF score below 60 (versus 37.2%, P = .03) compared with
the nonmisusers (Table 3).
3.4. The Logistic Regression Model for Treatment Attendance.
When age and sex were adjusted, and selected depression
severity and comorbidity variables entered into the model,
the strongest clinical- or treatment-related factor signiﬁ-
cantly associating with attendance (proportion of kept to
scheduledindividualappointments)wasthebaselineAUDIT
score (Wald χ2 = 56.009, df = 1, P<. 001, OR 0.97; 95%
CI 0.96, 0.97; Table 4).
4. Discussion
The comparisons between depressed adolescent outpatients
with and without alcohol misuse yielded some important
signiﬁcantdiﬀerences.Speciﬁcally,thosewithalcoholmisuse
had perceived less social support from their families. In addi-
tion,theirparentsoftenhadmoreproblemswithalcoholuse.
These results are in line with previous ﬁndings indicating a
number of family-related factors, such as parental substance
use or abuse, poor parent-child relationships, low perceived
parental support, poor communication, and poor parent
supervision and management of the adolescent’s behaviour,
asriskfactorsforthedevelopmentofsubstanceabuseamong
adolescents in general [53].
Further, those with alcohol misuse had more depressive
symptoms and poorer psychosocial functioning both at the
baseline and still after a one-year follow-up period time,
which is in line with the ﬁndings by Goldstein et al. [11].
Our results were expected as Meririnne et al. [12] recently
reported from the ADS study that alcohol use negatively
aﬀects the course of adolescent depression and psychosocial
functioning. It is also important to notice, that even after
a one-year follow-up period the AUDIT scores were still
very high for the alcohol misuse group, and indicated an
increasing trend for the nonmisusers. Further, our study
supports the previous ﬁndings that not only boys but also
depressed girls appear to be at a risk for substance use
involvement during adolescence [5]. This is particularly
interesting, as recent observations of increasing drinking
among girls have raised public concern.
The diﬀerences in treatment received between the two
groups were, as a whole, only minor: those with alcohol
misuse had more often received psychotrophic medication
altogether compared to the nonmisusers. These minor
diﬀerences in treatment may reﬂect the fact that substance-
related problems were either not detected at all or not taken
into account when planning the treatment. This may lead
to insuﬃcient treatment, as Couwenbergh et al. [27]h a v e
pointed out. On the other hand, as the outpatients with
alcohol misuse had more severe symptoms of depression,
they were probably more often prescribed psychotropic
medication. The possible problems recognizing alcohol use
and not taken into account when formulating treatment
for depressed adolescents may at least reﬂect (1) the lack
of suﬃcient knowledge and expertise to assess and treat
substance use problems, (2) the way the clinicians concep-
tualize their work (treat mental disorders versus SUDs), (3)
the way the clinicians interpret the level of adolescents sub-
stance use (part of normative development versus disturbed
development), (4) level of trust and therapeutic alliance
between the adolescent and clinician, and (5) adolescent’s
own thoughts or feelings about his/her substance use leading
to underreported or nondisclosure of substance use.
Compared to, for example, practice parameters by the
American Academy of Child and Adolescent Psychiatry
(2007) [23], one may see at least one signiﬁcant shortcoming
in treatment: the exiguity of family and school involvement
in treatment. According to the practise parameter for the
assessment and treatment of children and adolescents with
substance use disorders [53], family therapy or signiﬁcant
family/parental involvement are critical to the success of any
treatment approach for adolescents with SUDs. Our ﬁndings
on signiﬁcant parental problems with alcohol among ado-
lescents with alcohol misuse may indicate that the parents
themselves were so severely distressed that the adolescents
were left too alone in the family in their eﬀorts to get help
for their problems. In addition, from the adolescent devel-
opmental perspective, growing eﬀorts to independence from
the parents are commonly seen as an age-related behaviour,Depression Research and Treatment 7
andtheparentsmayhavemisinterpretedadolescents’alcohol
use as such as a “normal” behavior. Although some degree
of risk-taking may be normal in adolescence, repeated
engagement in high-risk activities, persistent disregard for
attempts at limit setting by authority ﬁgures, and aggressive
behavior may be signs of a more serious problem [54]. Thus,
both the parents and the clinicians should not interpret too
easilyadolescent’s alcoholuseasnormative experimentation.
Interestingly, ﬁndings from this naturalistic clinical one-
year follow-up study of depressed psychiatric outpatient
adolescents indicate that an adolescent’s severity of alcohol
use, even at subdiagnostic level, has an independent negative
eﬀect on attendance at individual treatment appointments,
which, for its part, most likely has a negative eﬀect on out-
come. Haw et al. [55] have concluded that both comorbidity
with alcohol abuse and poor compliance with treatment
may be important factors complicating therapy in many
depressed patients with deliberate self-harm. As outpatient
nonattendance is a serious problem in clinical and economic
terms, wemust at leasttry to speculatethe reasonsforpoorer
attendance. A number of family factors, such as parental
involvement in treatment and family cohesion, have been
identiﬁed as factors relating to treatment compliance among
adolescent suicide attempters [56]. As mentioned above, this
could be the case also in this study as depressive adolescents
w i t ha l c o h o lm i s u s eh a dp e r c e i v e dl e s ss o c i a ls u p p o r tf r o m
their families and their parents often had more problems
with alcohol use. The adolescents may miss their treatment
appointments also because of the direct negative impact of
alcohol use on functioning (intoxication, hangover, or guilt),
and the absence of subjective need for help (not seeing
current pattern of alcohol use as a problem). In addition,
regular alcohol use may complicate or even hinder recovery,
leading to subjective disappointments in treatment.
Interestingly, in the logistic model, an association was
noted between an axis II comorbidity and treatment atten-
dance. This may suggest that special emphasis was placed on
the treatment of those depressed individuals with comorbid
personality disorders. This ﬁnding is to be studied in more
detail in the near future.
In developing adolescent treatment settings and services,
morespeciﬁctreatmentoptionsareneededregardingalcohol
use problems, for instance. This would require identiﬁcation
of diﬀerent clinical presentations of disorders and sub-
threshold disorders, and subsequent education of personnel
accordingly. As an example, failures to keep appointments
should alert for potential alcohol or other substance use
problem.
4.1. Study Limitations. The present one-year follow-up
study included consequently referred depressed adolescent
outpatients, whose psychiatric diagnoses and clinical char-
acteristics were comprehensively assessed using a reliable
interview instrument and self-report scales. Alcohol use was
assessed by a self-report scale of AUDIT using a cutoﬀ
point of 8 points [35, 36]. Lower cutoﬀ points have also
been suggested for use among adolescents [38]; however,
we aimed at studying alcohol use “severe enough” but not
necessarily meeting diagnostic criteria for actual substance
usedisorders.Itiscriticallyimportanttoassessthepredictive
meaning of alcohol misuse among depressed adolescents in
order to ﬁnd out eﬀective treatments in ordinary clinical
practice.
There is a possibility that the study ﬁndings are not
exclusive to alcohol misuse, being perhaps inﬂuenced by
other substances. However, this is unlikely as the number of
other substance-related diagnoses was small.
Generalization of the ﬁnding to other cultures should be
made with the understanding of possible diﬀerences between
health care systems. Due to the Finnish system, adolescents
believed to have a predominant and severe substance use
disorders were treated elsewhere in specialized units.
This is a naturalistic clinical follow-up study, so any
conclusions regarding the actual eﬀect of the treatment on
the outcome are precluded. On the other hand, naturalistic
follow-up data are useful in assessing other questions,
for example, factors associating with treatment adherence
among “real-life” outpatients.
Due to the descriptive nature of the data, we reported
the values for all the collected treatment-related variables.
As these were numerous, a possibility for signiﬁcant ﬁndings
by chance arises. In the context of a relatively small study
population, we wanted to avoid missing possible signiﬁcant
ﬁndings(atypeIIerror)anddecidedtousebasicsigniﬁcance
testswithoutadjustmentsforthesigniﬁcancelevel,whilerec-
ognizing that in so doing some of the statistically signiﬁcant
eﬀects may be spurious.
5. Conclusions
Alcohol misuse was related to lower perceived parental
support and greater parental alcohol use problems among
depressedadolescentoutpatients.Further,thosewithalcohol
misuse had more depressive symptoms and poorer psy-
chosocial functioning both at the baseline and still after
one-year-follow-up period time. An adolescent’s severity of
alcohol use, even at subdiagnostic level as measured by
self-report questionnaire and had an independent negative
eﬀect on attendance at individual treatment appointments,
which, for its part, most likely had a negative eﬀect on
outcome. Early recognition of alcohol misuse is most
important among adolescents in primary level treatment
and other service settings. It should not be overlooked
either in specialized settings focusing on the assessment
and treatment of predominantly psychiatric disorders like
depressive disorders. This view emphasizes the need for
integrated services, having potential for simultaneous inter-
ventions and tolerance for both substance-related and other
psychiatricproblems.Amongadolescents,theeﬀectoffamily
to attrition from treatment may be greater than thought.
This should perhaps be taken into account by favour-
ing family-related psychosocial methods, when possible,
particularly in substance-related psychiatric problems. It
seems that for depressed adolescents with alcohol and other
substance-related problems speciﬁc multimodal treatment
programs, accepted by adolescents and their parents, are
needed.8 Depression Research and Treatment
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